Guest ICIS Symposium at virtual AAI meeting IMMUNOLOGY2021, May 13, 2021 Emerging Roles of Type III Interferons in COVID-19, Gut Microbiome, Adaptive Immunity, and Anti-Fungal Immunity The symposium started with a brief overview of type III IFNs by Sergei Kotenko, Rutgers University. He covered discoveries leading to the identification of [READ MORE]
The Annual International Meeting of Korean Association of Immunologists (KAI 2021) was held on June 2 – 4, 2021 at the Swiss Grand Hotel in Seoul, Korea. Despite the continuing global COVID-19 pandemic and a strict social distancing policy in Korea, the on/offline hybrid meeting was highly successful with about 900 participants (181 abstracts) from 21 countries. The scientific program included 4 plenary lectures, 14 Major Symposia, 3 Satellite Symposia, 6 Workshops, 2 Education Sessions, and many Industry Symposia. The plenary lectures were given by Mi-Na Kwon (Korea), Laurence Zitvogel (France), Mark Davis (USA), and Ruslan Medzhitov (USA). More information on KAI 2021 can be found at https://kai2021.org/register/KAI2021/main.html. KAI 2022 is planned to be held on Nov. 3 – 5, 2022 at the Dragon City Hotel in Seoul, Korea.
The Korean Association of Immunologists (KAI) is the national society of immunology researchers that includes basic immunologists and clinicians. KAI started in1974 with 48 inaugural members and has grown to have more than 3,000 current members. This year KAI is sponsoring one scientific session at Cytokines 2021 on Cytokines and Bystander T Cell Activation.
This monthly webinar series has been extremely successful, setting a gold standard in quality and accessibility, with over 1500 registered users from over 300 international institutions and companies. This platform has provided an excellent opportunity for immunologists active in innate Immune research within Cambridge and internationally, to continue discussions and share findings. [READ MORE]
Thursday, May 13, 2021 5:00 PM ET – 7:00 PM ET
International Cytokine and Interferon Society (ICIS) Symposium
Emerging Roles of Type III Interferons in COVID-19, Gut Microbiome, Adaptive Immunity, and Anti-Fungal Immunity
Ludmila Prokunina-Olsson, NCI, NIH
Sergei V. Kotenko, Rutgers Univ.
Kristin A. Hogquist, Univ. of Minnesota, Distinct roles for type I and III interferons in thymic selection
Megan T. Baldridge, Washington Univ. Sch. of Med., Restriction of intestinal viral cellular tropism by IFN-λ
Amariliz Rivera, Rutgers Univ., Novel insights on IFN-λ in innate anti-fungal immunity
Ivan Zanoni, Harvard Med. Sch., Impact and regulation of type III interferon production in COVID-19
Ludmila Prokunina-Olsson, NCI, NIH, Type III interferon and the genetics of COVID-19 [READ MORE]
Due to the Covid-19 pandemic preventing us to meet in person, the 34th EMDS conference has been converted into an online meeting.
The Abstract submission portal is open. Deadline for submission of abstract: 30 April 2021.
Deadline for registration: 31 May 2021.
More Information: https://conferences.au.dk/EMDS/ [READ MORE]